Article

Carl Zeiss Meditec owns majority interest

Jena, Germany—Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

Jena, Germany-Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

The German company had acquired about 63% of the IOLTech shares from its former principal shareholder as of Feb. 1. About two-thirds of the remaining minority shareholders accepted Carl Zeiss Meditec's voluntary public takeover bid by April 5.

"The company considers this result of the takeover bid as a further successful milestone on Carl Zeiss Meditec's way to the complete takeover of IOLTech," Carl Zeiss Meditec announced.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.